The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Abeona Therapeutics Inc COM 00289Y107 11,740 2,359,767 SH   SOLE   2,359,767 0 0
Amicus Therapeutics Inc. COM 03152W109 357 50,000 SH   SOLE   50,000 0 0
Advaxis Inc. W EXP 07/15/201 007624117 500 112,500 SH   SOLE   112,500 0 0
Alcobra Ltd SHS M2239P109 1,374 1,205,498 SH   SOLE   1,205,498 0 0
Aldeyra Therapeutics Inc COM 01438T106 620 124,096 SH   SOLE   124,096 0 0
Ampio Pharmaceuticals Inc. COM 03209T109 2,191 2,738,322 SH   SOLE   2,738,322 0 0
Anavex Life Sciences Corp COM NEW 032797300 4,157 724,205 SH   SOLE   724,205 0 0
Caladrius Biosciences Inc COM NEW 128058203 593 117,957 SH   SOLE   117,957 0 0
Corbus Pharmaceuticals HLDGS COM 21833P103 30,846 3,738,925 SH   SOLE   3,738,925 0 0
Evoke Pharma Inc COM 30049G104 543 175,000 SH   SOLE   175,000 0 0
Keryx Biopharmaceuticals Inc. COM 492515101 1,232 200,000 SH   SOLE   200,000 0 0
Newlink Genetics Corp COM 651511107 2,254 93,533 SH   SOLE   93,533 0 0
Neurotrope Inc COM NEW 64129T207 867 45,388 SH   SOLE   45,388 0 0
Ritter Pharmaceuticals, Inc COM 767836109 1,139 802,434 SH   SOLE   802,434 0 0
Summit Therapeutics PLC SPONS ADS 86627R102 1,327 100,000 SH   SOLE   100,000 0 0
Vascular Biogenics LTD COM M96883109 4,733 860,605 SH   SOLE   860,605 0 0
Volition RX LTD COM 928661107 1,855 461,538 SH   SOLE   461,538 0 0